Table 3.
Polymer | Structure | Biodegradation | Properties | Vaccine delivery method | Ref. |
---|---|---|---|---|---|
Polyesters | |||||
Poly(ε-caprolactone) (PCL) | 2–4 years |
Does not generate acidic environment upon degradation Adjuvant properties Slow degradation only suitable for long-term delivery applications |
NP, MP | 189 | |
Poly(lactic acid) (PLA) | 3–8 months |
Tunable degradation depending on chirality of monomers Adjuvant properties |
NP, MP | 190 | |
Poly(lactic-co-glycolic acid) (PLGA) | 1–6 months |
Tunable degradation depending on monomer ratios in copolymer Degradation produces acidic environment Protein encapsulation can cause denaturation |
NP, MP, MN | 118 | |
Polyanhydrides | |||||
Poly[1,6-bis(p-carboxyphenoxy)hexane-co-sebacic acid] (PCPH-SA) | 2–10 weeks |
Tunable degradation and material properties owing to synthetic flexibility Adjuvant properties Freezing and anhydrous conditions required for storage |
NP, MP | 127 | |
Polyphosphazene | |||||
Poly[di(carboxylatophenoxy)phosphazene] (PCPP) | 1–24 months |
Tunable degradation and material properties owing to synthetic flexibility Buffering capacity of degradation products Adjuvant properties |
NP, MP, coated MN | 191 | |
Polysaccharides | |||||
Chitosan | 14–60 days |
Encapsulation of antigens in aqueous media Mucoadhesive properties Adjuvant properties High variability in quality from commercial sources can affect degradation and immunogenicity |
NP, MP, MN, coated MN | 144 | |
Hyaluronic acid (HA) | <24 hours |
Rapid dissolution in the skin Adjuvant properties Not suitable for long-term delivery applications |
MN | 192 | |
Dextran | 1–42 hours |
Rapid dissolution in the skin Microparticle formulations require chemical modification of dextran |
MP, MN | 193 | |
Alginate | NA |
Encapsulation of antigens in aqueous media Mucoadhesive properties Adjuvant properties Stable at low pH, facilitating oral immunization High variability in quality from commercial sources can affect degradation and immunogenicity Limited in vivo degradation unless chemically modified |
MP, MN | 194 | |
Non-biodegradable polymers | |||||
Polyvinylalcohol (PVA) or polyvinylpyrrolidone (PVP) | NA |
Rapid dissolution in the skin Non-biodegradable |
MN | 195 |
MN, microneedle; MP, microparticle; NA, not applicable; NP, nanoparticle.